Evidence map›Paper›PMID 23584064›Full record

ReviewAlcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism2010

Focus on the liver: alcohol use, highly active antiretroviral therapy, and liver disease in HIV-infected patients.

Shirish Barve, Rama Kapoor, Akshata Moghe, Julio A Ramirez, John W Eaton, Leila Gobejishvili, Swati Joshi-Barve, Craig J McClain

Open access · greenAbstract readReview
In one paragraph

Review in Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed, 2 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 2 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Reasons for limiting drinking in an HIV primary care sample.Alcoholism, clinical and experimental research · 2014
    Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Liver disease in people living with HIV infection: a changing landscape.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Shirish BarveUniversity of Louisville, Louisville, Kentucky.
Rama Kapoor
Akshata Moghe
Julio A Ramirez
John W Eaton
Leila Gobejishvili
Swati Joshi-Barve
Craig J McClain
University of Louisville · US

Funding

S-adenosylhomocysteine and S-adenosylmethionine in Alcoholic Liver DiseaseR01AA015970 · NIAAA · UNIVERSITY OF LOUISVILLE · PI MCCLAIN, CRAIG J. · 2005 to 2010
$2.0M
Mechanisms of Alcohol-Induced ImmunosuppressionR01AA014371 · NIAAA · UNIVERSITY OF LOUISVILLE · PI BARVE, SHIRISH S · 2004 to 2010
$1.6M
NIAAA NIH HHS AA-014371NIAAA NIH HHS AA-015970
6 · The paper itself

Abstract

Since the introduction of highly active antiretroviral therapy (HAART) in the 1990 s, liver disease is emerging as a major cause of morbidity and mortality among HIV-infected patients. This is attributed to a variety of factors, including HAART hepatotoxicity, coinfection with hepatitis B and C virus (HBV and HCV, respectively), and alcohol abuse. Several studies have examined the effects of HAART and HCV/HBV coinfection on liver toxicity. However, the impact of alcohol consumption as a cofactor for hepatotoxicity in HIV patients is only beginning to be understood. Similar to the general population, alcohol use is common in the HIV population but is often overlooked by health care providers. Approximately 25 percent of recently diagnosed HIV patients are alcohol dependent; moreover, alcohol dependence has been associated with HIV treatment failure. Alcohol/HAART interactions appear crucial for the development of liver disease in HIV patients. Recent research has shown that alcohol abuse is associated with severe hepatotoxicity in patients on HAART. Importantly, alcoholic- and HAART-induced liver disease share many potential mechanisms of injury, including altered metabolism of certain signaling molecules (i.e., cytokines) and dysfunction of some cell components (i.e., proteasomes and mitochondria).

Indexed as

Alcohol DrinkingAlcoholismAnimalsAntiretroviral Therapy, Highly ActiveCytokinesHIV InfectionsHumansLiverLiver DiseasesCytokines

Identifiers

PMID23584064
PMCPMC3860514
OpenAlexW1554951034

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.